Clinical Trials Directory

Trials / Unknown

UnknownNCT03367624

Epidemiology of Post-influenza Bacterial Pneumonia Due to a Panton-Valentine Leukocidin Positive Staphylococcus Aureus

Status
Unknown
Phase
Study type
Observational
Enrollment
35 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Secondary bacterial influenza pneumonia caused by Panton-Valentine Leukocidin Positive Staphylococcus aureus is a rare complication but with poor prognosis. This pathology seems to affect young patients (20-40 years) without any medical history. Since the influenza pandemic of 2009, this complication is more and more mentioned, sought and diagnosed. However, the literature is poor, consisting of case reports, experimental studies on murine models, and low-power studies. The main objective is to evaluate the mortality in intensive care units of patients post-influenza bacterial pneumonia due to a Panton-Valentine Leukocidin positive Staphylococcus aureus

Conditions

Timeline

Start date
2017-10-01
Primary completion
2017-10-20
Completion
2018-03-01
First posted
2017-12-11
Last updated
2017-12-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03367624. Inclusion in this directory is not an endorsement.

Epidemiology of Post-influenza Bacterial Pneumonia Due to a Panton-Valentine Leukocidin Positive Staphylococcus Aureus (NCT03367624) · Clinical Trials Directory